Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 3 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 3

From: Role of 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography in assessment of neoadjuvant chemotherapy response in breast cancer patients

Fig. 3

48 years old female patient presented with clinically palpable right breast mass biopsy revealed IDC grade III. a Axial CECT image revealed right breast speculated soft tissue mass lesion measuring about 55 × 60 mm that was eliciting dense tracer fixation reaching 13.5 SULpeak in axial PET (b) and fused PET/CT (c) images. On follow-up after completion of chemotherapy, marked morphologic and metabolic regression of the mass was noted in the form of reduction in size (reaching 10 × 12 mm) in axial CECT image (d) denoting partial response and reduction in SULpeak (reaching 2.7) in axial PET (e) and fused PET/CT (f) images denoting partial metabolic response

Back to article page